Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Trillions of SNPs Versus a Glass of Grappa

David S. Pisetsky, MD  |  Issue: April 2011  |  April 13, 2011

In case you are worried, the technology to characterize the epigenome is also coming down the pike. At present, the throughput is a bit sluggish, but the pace will no doubt accelerate, and soon platforms will be available for genetic and epigenetic chipping. I am not sure how providers will be able to transfer all of this information to their patients. I can just imagine a conversation like the following: “Well, Mr. Jones, we just ran your genome and we have good news and bad news. The good news is that you have a cytosine at position number 163 of your TNF gene. The bad news is that it is methylated.” Good luck in explaining that one.

Throw Genetics to the Wind

At the end of the meeting, the attendees took buses downtown for a farewell party in an old schoolhouse that had been converted for conferences and dinner functions. Unlike the airport, which was situated beneath the roar of jets, the schoolhouse was an imposing building ornately decorated with spires and turrets and felt like old Europe. The banquet room had a high vaulted ceiling of rich mahogany, and the walls were covered with heraldic shields; carved wood heads of Arabs, Indians, and Africans; and statues representing the young girls who were the first female students of the school in the 1800s. From the high windows of the banquet hall, we could look out over the city, whose lights flickered and sparkled as darkness descended, and the chill of European winter forced its way in.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

At the end of a lovely dinner, I had a choice of kirsch, grappa, or cognac. I should have passed on an after-dinner drink because these libations are distillates filled with toxic chemicals worthy of the Love Canal. I am sure that one of these potions is more suited to my genetics than another; no doubt all three could do serious damage to my epigenome, scorching my intestines or pickling my brain. Nevertheless, I had just attended a wonderful meeting, I was with good friends, and my spirits were soaring under the influence of the Prosecco and Amarone that I had downed earlier in the evening.

While an ounce of prevention can be worth a pound of cure, it can also be a downer. So, imbued with the spirit of personalized matter and emboldened with the power of free will, I did what many people do having pondered their genetics. I decided to drink. I took the grappa.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 | Single Page
Share: 

Filed under:OpinionResearch RheumRheuminationsSpeak Out RheumTechnology Tagged with:geneticsResearchrheumatologistTechnology

Related Articles

    A Unique Structure for Tackling Psoriatic Disease

    June 13, 2011

    GRAPPA brings together a group of highly motivated physicians to address these complex disorders

    Experts Discuss the Latest Precision Medicine Research

    February 18, 2018

    SAN DIEGO—In just two decades, precision medicine has gone from futuristic concept to realistic toolbox for clinical physicians. At the 2017 ACR Clinical Research Conference on Nov. 3, the Precision Medicine in Rheumatic Diseases: Hopes and Challenges lecture featured rheumatologists and experts on genetics, genomics, pharmaco­genetics and big data who spoke about the latest research…

    Gene Manipulation Has Potential to Alter Genomes, Impact Society

    Gene Manipulation Has Potential to Alter Genomes, Impact Society

    January 19, 2016

    Every so often, a major scientific breakthrough profoundly alters the trajectory of scientific research. In the 1960s, microbiologists sparked the recombinant-DNA revolution with the discovery that bacteria have innate immune systems based on restriction enzymes. These enzymes bind and cut invading viral genomes at specific short sequences, and scientists rapidly repurposed them to cut and…

    Genome-Wide Association Studies of SLE

    February 12, 2011

    What do these studies tell us about disease mechanisms in lupus?

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences